← All companies
Amneal Pharmaceuticals, Inc.
AMRX - CIK 0001723128
Market cap$4.89 B
Rank#1397
SEC filings664
The table below shows Amneal Pharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $197.66M | $201.25M | $71.54M | $59.19M | $74.01M | $43.77M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $641.62M | $614.50M | $608.97M | $601.43M | $596.36M | $575.62M |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.